Dapper3 include a range of compounds that influence various signaling pathways within cells. Lithium Chloride, for instance, plays a significant role in activating the Wnt/β-catenin signaling pathway, which is crucial for the stabilization and accumulation of β-catenin in the cell. The increased levels of β-catenin can then translocate to the nucleus and initiate the transcription of Wnt target genes, a process where Dapper3 is known to be involved. Forskolin operates through a different mechanism, raising the cellular levels of cAMP, which in turn activates protein kinase A (PKA). The activation of PKA can lead to the phosphorylation of proteins that interact with Dapper3, thereby modulating its activity. Similarly, PMA acts as an activator of protein kinase C (PKC), which is also capable of phosphorylating signaling proteins that associate with Dapper3, playing a part in the non-canonical Wnt signaling pathway.
Compounds such as Epidermal Growth Factor (EGF) and Insulin trigger their respective receptors to start a cascade of signaling events. EGF activates its receptor leading to downstream signaling including the MAPK/ERK pathway, which can intersect with Dapper3 signaling. Insulin, through its receptor, can activate the PI3K/Akt pathway, another signaling route where Dapper3 has a role. Wnt3a is a direct activator of the canonical Wnt signaling pathway, potentially enhancing the activation state of Dapper3. GSK-3β inhibitors like 6-Bromoindirubin-3'-oxime (BIO) and SB-216763 prevent the degradation of β-catenin, leading to the activation of Dapper3 by promoting nuclear β-catenin signaling. Ionomycin, as a calcium ionophore, raises intracellular calcium levels, which activates calcium-sensitive signaling mechanisms that can interact with Dapper3. Anisomycin, by activating stress-activated protein kinases such as JNK, may influence the activation of Dapper3 involved in stress response pathways. Lastly, A-83-01 and PD98059, through the inhibition of TGF-β type I receptor ALK5 and MEK, respectively, might lead to the activation of Dapper3 by affecting non-Smad and alternative signaling pathways within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride activates the Wnt/β-catenin signaling pathway, which can lead to the activation of Dapper3 by promoting the stabilization and accumulation of β-catenin in the cell. β-catenin then enters the nucleus and activates Wnt target genes, which can include Dapper3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and thereby activate signaling proteins that interact with Dapper3, promoting Dapper3's role in non-canonical Wnt signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to a signaling cascade that can enhance the activation of Dapper3 through PI3K/Akt pathway, which is implicated in Dapper3-mediated cellular processes. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO inhibits GSK-3β, preventing the degradation of β-catenin, thus enhancing Wnt signaling which can lead to the activation of Dapper3 by increasing β-catenin's nuclear signaling potential. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763 is another GSK-3β inhibitor that leads to the accumulation of β-catenin in the nucleus, similar to BIO, thereby promoting the activation of Dapper3 via the canonical Wnt pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calmodulin-dependent kinase and other calcium-sensitive signaling mechanisms that interact with and lead to the activation of Dapper3. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases such as JNK, which could lead to the activation of Dapper3 through its role in signaling pathways affected by cellular stress. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
A-83-01 inhibits TGF-β type I receptor ALK5, which can enhance the activation of non-Smad signaling pathways, potentially leading to the activation of Dapper3 as it is involved in these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can lead to compensatory activation of alternative pathways within the cell, potentially leading to the activation of Dapper3 through cross-talk between pathways. | ||||||